Author

Christian Rolfo

Professor in Oncology, Head of Phase I -Early Clinical Trials Unit, Oncology, Antwerp University - Cited by 21,798 - thoracic oncology - liquid biopsies - exosomes - drug development - clincial trials

Biography

Dr. Christian Rolfo  is an Associate professor in the Oncology Department, University Hospital of Antwerp,Edegem, Antwerp, Belgium. His study interests major on Oncology. In recent years, he has studied thoracic oncology, liquid biopsies. Currently, Dr. Rolfo is the author/editors/reviewer in several international journals. He published 33 articles in many journals and the articles are informative and got good citations.
Title
Cited by
Year
Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer
D de Miguel-Perez, A Russo, O Arrieta, M Ak, F Barron, M Gunasekaran, ...Journal of Experimental & Clinical Cancer Research 41 (1), 1-14, 2022202
26
2022
The armed conflict and the impact on patients with cancer in Ukraine: Urgent considerations
C Caglevic, C Rolfo, I Gil-Bazo, A Cardona, J Sapunar, FR Hirsch, ...JCO Global Oncology 8, e2200123, 2022202
13
2022
Practical considerations for the use of circulating tumor DNA in the treatment of patients with cancer: a narrative review
MG Krebs, U Malapelle, F André, L Paz-Ares, M Schuler, DM Thomas, ...JAMA oncology, 2022202
12
2022
Small cell lung cancer: novel treatments beyond immunotherapy
JJ Meijer, A Leonetti, G Airò, M Tiseo, C Rolfo, E Giovannetti, M VahabiSeminars in Cancer Biology 86, 376-385, 2022202
11
2022
STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP)
VCC de Lima, M Corassa, E Saldanha, H Freitas, O Arrieta, L Raez, ...Lung Cancer 170, 114-121, 2022202
8
2022
The evolving role of liquid biopsy in lung cancer
U Malapelle, P Pisapia, F Pepe, G Russo, M Buono, A Russo, J Gomez, ...Lung Cancer, 2022202
8
2022
Baseline extracellular vesicle TGF‐β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non–small cell lung cancer
D de Miguel‐Perez, A Russo, M Gunasekaran, F Buemi, L Hester, X Fan, ...Cancer 129 (4), 521-530, 2023202
8
2023
The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis
A Galvano, L Castellana, V Gristina, M La Mantia, L Insalaco, N Barraco, ...Therapeutic Advances in Medical Oncology 14, 1758835922111012, 2022202
6
2022
Emerging noncoding RNAs contained in extracellular vesicles: rising stars as biomarkers in lung cancer liquid biopsy
G Cammarata, D de Miguel-Perez, A Russo, A Peleg, V Dolo, C Rolfo, ...Therapeutic Advances in Medical Oncology 14, 175885922111229, 2022202
3
2022
Mechanisms of resistance to first-line osimertinib in Hispanic patients with EGFR mutant non-small cell lung cancer (FRESTON-CLICaP)
AF Cardona, A Ruiz-Patiño, G Recondo, C Martín, L Raez, S Samtani, ...Clinical Lung Cancer 2 (6), 522-51, 2022202
3
2022
Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer
C Rolfo, E Giovannetti, P Martinez, S McCue, A NaingNPJ Precision Oncology 7 (1), 6, 030
2
2023
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer
E Al-Obeidi, JW Riess, U Malapelle, C Rolfo, DR GandaraHematology/Oncology Clinics 37 (3), 475-487, 030
2
2023
Nitroglycerin Plus Whole Intracranial Radiation Therapy for Brain Metastases in Patients With Non-Small Cell Lung Cancer: A Randomized, Open-Label, Phase 2 Clinical Trial
O Arrieta, N Hernández-Pedro, F Maldonado, M Ramos-Ramírez, ...International Journal of Radiation Oncology* Biology* Physics 5 (3), 592-607, 2023202
1
2023
Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways
G Mountzios, GL Banna, C RolfoFrontiers in Oncology 2, 997404, 2022202
1
2022
NPY Methylated ctDNA is a Promising Biomarker for Treatment Response Monitoring in Metastatic Colorectal Cancer
K Janssens, G Vanhoutte, W Lybaert, W Demey, J Decaestecker, ...Clinical Cancer Research 29 (9), 74-750, 2023202
1
2023
Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an …
DF Chamorro, AF Cardona, J Rodríguez, A Ruiz-Patiño, O Arrieta, ...Targeted Oncology 8 (3), 425-440, 2023202
1
2023
External control cohorts for the single-arm LIBRETTO-001 trial of selpercatinib in RET+ non-small-cell lung cancer
External control cohorts for the single-arm LIBRETTO-00 trial of selpercatinib in RET+ non-small-cell lung cancerC Rolfo, LM Hess, MH Jen, P Peterson, X Li, H Liu, Y Lai, T Sugihara, ...ESMO open 7 (4), 0055, 2022202
1
2022

Referred From: https://scholar.google.com/citations?hl=en&user=zQY83SMAAAAJ

Cited by
Citations 21798
h-index 59
i10-index 228
Recommended Journals
Open Access Journals